Asthma Explained Clearly

Course Overview

Asthma Explained Clearly is a course designed to clarify, review, and augment the training and understanding of primary care clinicians in their understanding of asthma. The module included in this course takes a departure from the traditional slide presentation style lecture. Instead, the course is comprised of a video lecture aided by real-time instructor-led chalkboard visuals. This method of learning allows for the subject matter to be broken down to the basics and is designed to increase learning and retention. Asthma Explained Clearly covers the nature of asthma and how it is diagnosed, the signs and symptoms of asthma, and the treatment after diagnosis. This CME course will utilize a combination of video and systematic discussion of clinical scenarios and practice cases to effectively deliver the course content.

Course Objectives: 

As a result of this educational activity, participants should be better able to: 

• Describe a systematic approach to asthma diagnosis and treatment modalities according to current guidelines
• Demonstrate a comprehensive understanding of pharmacological interventions for asthma management, including appropriate medication selection, dosing, monitoring, and adjustment.
• Discuss the lifestyle changes related to improving asthma and develop the ability to tailor advice based on individual patient needs.

Post-Test and Evaluation:

After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. 

Faculty

Roger D. Seheult, MD
Pulmonary, Critical Care, and Sleep Medicine
Optum Medical Group, Redlands, CA
Associate Clinical Professor
UC Riverside School of Medicine, Riverside, CA
Assistant Professor of Medicine
Loma Linda University School of Medicine
Loma Linda, CA

Accreditation

AMA PRA Category 1 Credits™: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Continuing Education Company, Inc. and MedCram, LLC. Continuing Education Company, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

Continuing Education Company, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC)program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.25 hours of Category 1 credit for completing this activity. 

AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 1.25 hours of participation, 0.5 of which can be used towards Pharmacology, for completing this activity.

Release Date: 1/12/2024

Expiration Date: 1/12/2027(Date after which this enduring material is no longer certified for credit.)

Medium: Internet/Enduring Material, Video/Audio

Faculty/Planning Committee Disclosures

Review and Planning Committee:

Disclosures: The following individuals have indicated that they have no financial relationships with an ineligible company:

Beth Ryan Townsend, CHCP–Reviewer (Continuing Education Company)

Kyle Allred, PA-C-Planner & Content Developer (MedCram)

Faculty Disclosures:

The following individuals were responsible for developing their own content, which has been reviewed by Continuing Education Company’s Medical Education Advisory Committee to ensure it is unbiased. Continuing Education Company has ensured that all relevant financial relationships that faculty may have with ineligible companies have been mitigated in advance of the CME activity. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Roger Seheult,MD         Consultant: Intrivo

Unlabeled Use Declaration:

During their presentation, faculty may discuss unlabeled or investigational use which is not approved fora commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.

Statement of Disclosure and Independence:

It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor. All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above. 

The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.

Computer Requirements

One of the following browsers:

•  Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
•  Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
•  Linux: Firefox 1.x and later

HTML5 via one of the following browsers:

•  Windows: Google Chrome (latest version)
•  Mac: Safari 6.0.5 or later, Google Chrome (latest version)
•  Mobile: Safari in Apple iOS 6 or later

Roger Seheult M.D. is approved by the California Board of Registered Nursing, Provider # CEP16824.  This course is approved for 1.25 CE contact hours.